Health Care

Can Valeant Save Itself?

Valeant Pharmaceuticals International Inc will sell billions of dollars of non-core assets and could accept offers for its main businesses, its chief executive said on Tuesday, as the drugmaker worked to restore investor trust after a year of bad news.

What Nest Egg? Two-Thirds of Americans Can't Cover $1,000 Emergency

You have finally reached your retirement age and are feeling comfortable that your nest egg will take care of your financial needs for as long as you need. But do you have an emergency slush fund set up for those unforeseen home repair or medical expenses?

Humana Posts Surprise Rise in Revenue

Humana reported better-than-anticipated earnings and a surprise rise in revenue in the most recent quarter as a key measure of the company's medical costs fell.

Fitbit Profit Underperforms

Wearable device maker Fitbit Inc reported a 10.5 percent fall in quarterly profit as the company continues to invest heavily amid rising competition.

Aetna Will Not Expand Obamacare Business in 2017

Aetna Inc said on Tuesday that it no longer planned to expand its Obamacare business next year and would sell some Medicare Advantage assets as it fights to gain antitrust regulators' approval for its takeover of Humana Inc .

Aetna Will Not Expand Obamacare Business in 2017

Aetna Inc said on Tuesday that it no longer planned to expand its Obamacare business next year and would sell some Medicare Advantage assets as it fights to gain antitrust regulators' approval for its takeover of Humana Inc .

Report: Biogen Targeted as Takeover Target

Biotechnology giant Biogen Inc has drawn takeover interest from drug companies including Merck & Co Inc and Allergan Plc, the Wall Street Journal reported, citing people familiar with the matter.